Spearhead Capital Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$11.56 - $19.76 $531,216 - $908,031	-45,953 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$11.18 - $15.46 $4,460 - $6,168	399 Added 0.88%	45,953 $636,000
Q3 2021 Oct 27, 2021	SELL	$14.21 - $17.65 $1,875 - $2,329	-132 Reduced 0.29%	45,554 $655,000
Q2 2021 Aug 10, 2021	BUY	$9.5 - $17.24 $34,352 - $62,339	3,616 Added 8.6%	45,686 $722,000
Q1 2021 Apr 28, 2021	BUY	$7.37 - $13.61 $310,055 - $572,572	42,070 New	42,070 $428,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.